Human Papilloma Virus in Italy: Cost of Illness and Potential Savings Due to HPV9 Primary Prevention

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.2291
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Awareness of Women About Cervical Smear, Human Papilloma Virus and Human Papilloma Virus Vaccine

Turk Jinekoloji ve Obstetrik Dernegi Dergisi
GynecologyObstetrics
2019English

Human Papilloma Virus Vaccines

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2013English

Human Papilloma Virus and Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2006English

Biologi Molekuler Human Papilloma Virus

Jurnal Ilmu Kedokteran
2018English

A Cost-Utility Analysis of Cervical Cancer Screening and Human Papilloma Virus Vaccination in the Philippines

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Using HIV Drugs to Target Human Papilloma Virus

Expert Review of Anti-Infective Therapy
VirologyInfectious DiseasesMicrobiology
2014English

The Cost of Illness Attributable to Diabetic Foot and Cost-Effectiveness of Secondary Prevention in Peru

BMC Health Services Research
Health Policy
2015English

Cost of Illness Analysis of Duchenne Muscular Dystrophy in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Cost of Illness of Spinal Muscular Atrophy (SMA) in Italy

Global and Regional Health Technology Assessment
Health Policy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy